CSF3 and graft versus host disease: Infusing ISO during HSC collections after G-CSF mobilization favorably modulates graft composition by enriching beneficial cell populations such as CD34+ hematopoietic stem/progeneitor cells, NK cells, and TCR-γδ T cells, while reducing B cells and CD4+ T cells that are known to be associated with adverse outcomes such as GvHD.